Member Log-in

I forgot my password

Not a Member? Register

Focus Area: <span>Evaluating cost and cost-effectiveness of immunization programs</span>

Results 1 -10 of 33

Webinar Resources: Using PATH’s Vaccine Cost Calculators to Inform Immunization Decision-making

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning how PATH’s Vaccine Cost Calculators can help provide an easy way for country-level decision-makers to assess and compare the costs of specific vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision-makers should use these cost calculators to assess and compare the costs of certain vaccination programs and determine the cost effectiveness and feasibility of introducing the vaccines in their country.

Continued

Webinar: Using PATH’s Vaccine Cost Calculators to Inform Immunization Decision-making

01/21/2021

Zoom Webinar

PATH, in collaboration with TechNet-21, the East African Community (EAC) Immunization Group, and the Vaccine Procurement Practitioners Network (VPPN), are delighted to invite you to join a webinar on using PATH’s Vaccine Cost Calculators to inform immunization decision-making.  Webinar title: Using PATH’s Vaccine Cost Calculators to inform immunization decision-making Date and Time: Thursday, 21 January from 09:00-10:00 CET Description: For country-level policymakers, the opportunity to introduce a new … Continued

How to Cost Immunization Programs: A Practical Guide on Primary Data Collection and Analysis

LOOK AT THIS IF YOU'RE INTERESTED IN:

Using methods related to collecting and analyzing primary data from a sample of health facilities to assess costs of routine immunization services.

HOW YOU CAN USE THIS MATERIAL:

Country immunization program staff and their teams can use this practical guidance to assess the costs of routine immunization services, including the delivery costs of those services,

Continued

PATH Brief: Economic Implications of Switching Rotavirus Vaccine Products in Palestine’s Immunization Program

LOOK AT THIS IF YOU'RE INTERESTED IN:

Comparing the overall costs, impact, and cost-effectiveness of both ROTARIX® and ROTAVAC® rotavirus vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision makers can learn from the experience of Palestine switching from ROTARIX® and ROTAVAC® to determine which vaccine offers the greatest impact and cost-effectiveness in their setting.

OVERVIEW:

The Palestinian Ministry of Health (MOH) introduced the rotavirus vaccine ROTARIX® in its routine immunization program in 2016.

Continued

PATH’s Vaccine Cost Calculators

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning how PATH’s Vaccine Cost Calculators can help provide an easy way for country-level decision-makers to assess and compare the costs of specific vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision-makers should use these cost calculators to assess and compare the costs of certain vaccination programs and determine the cost effectiveness and feasibility of introducing the vaccines in their country.

Continued

Enroll in Upcoming Vaccine Economics Online Course

The Teaching Vaccine Economics Everywhere (TVEE) training workshop will now be available online and is open to participants free-of-charge. Health economists from universities around the world have developed an online course to strengthen skills related to economics and financing of national immunization programs and to improve the sustainability of vaccine delivery in low and middle-income … Continued

Assessing the Incremental Costs and Savings of Introducing Electronic Immunization Registries and Stock Management Systems: Evidence from the Better Immunization Data Initiative in Tanzania and Zambia

Introduction: poor data quality and use have been identified as key challenges that negatively impact immunization programs in low- and middle-income countries (LMICs). In addition, many LMICs have a shortage of health personnel, and staff available have demanding workloads across several health programs. In order to address these challenges, the Better Immunization Data (BID) Initiative introduced a comprehensive suite of interventions,

Continued

New Evidence Shows Investments in Vaccination Produce Even Greater Returns than Previously Thought

This article originally appeared on Gavi’s website.  The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing ten infectious diseases in 94 low- and middle-income countries, including 73 countries that have received support from … Continued

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

ABSTRACT

Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full benefits. We estimated economic benefits using cost-of-illness and value-of-a-statistical-life approaches and combined this estimation with immunization program costs to derive the return on investment from immunization programs against ten pathogens for ninety-four low- and middle-income countries for the period 2011–30.

Continued

Immunization Delivery Cost Catalogue (IDCC)

The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, current, and standardized global evidence on the cost of delivering vaccines. In January 2017 and again in April 2018 and December 2019, ThinkWell completed a systematic review of the current evidence base on immunization delivery costs (IDC)*. The IDCC was built to answer a question frequently asked by national and global immunization stakeholders: “What are the unit costs of vaccine delivery across different LMICs and through a variety of delivery strategies?”

Continued

Choose a Language